Matrix Metalloproteinase-9 Is Increased in Obese Subjects and Decreases in Response to Pioglitazone
Open Access
- 1 June 2010
- journal article
- research article
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 95 (6) , 2993-3001
Abstract
Context: The study investigated the regulation of matrix metalloproteinases (MMP)-9 in obesity-associated insulin resistance in humans. Objectives: The objectives of the investigation were to study MMP-9 regulation by insulin resistance and pioglitazone treatment in impaired glucose tolerant subjects using adipose tissue biopsies and study the mechanism of MMP-9 regulation by pioglitazone in adipocyte cultures. Research Design: 86 nondiabetic, weight-stable subjects between 21 and 66 yr of age were recruited in a university hospital research center setting. All subjects underwent a sc adipose tissue incisional biopsy from the lower abdominal wall and insulin sensitivity testing using a frequently sampled iv glucose tolerance test. Impaired glucose-tolerant subjects were randomized to receive metformin or pioglitazone for 10 wk. To study the mechanism of MMP-9 regulation in adipocytes, cells were treated with pioglitazone or protein kinase Cα antisense oligomers, and MMP-9 levels were examined. Results: There was a positive correlation between MMP-9 and body mass index (r = 0.40, P < 0.01) and negative correlation between MMP-9 and insulin sensitivity (r = −0.46, P < 0.001). The improvement in insulin sensitivity from pioglitazone resulted in a 52 ± 0.2% reduction in MMP-9 mRNA. Fractionation of adipose tissue indicated that MMP-9 was mostly in the stromal vascular fraction. Pioglitazone also decreased MMP-9 in 3T3-F442A adipocytes and THP1 macrophages. Coculture of adipocytes with macrophages augmented MMP-9 expression in adipocytes and pioglitazone decreased MMP-9 in both adipocytes and macrophages. Conclusion: These data indicate that MMP-9 is elevated in insulin resistance and is reduced by pioglitazone.Keywords
This publication has 33 references indexed in Scilit:
- Reduced Adipose Tissue Oxygenation in Human ObesityDiabetes, 2009
- Adipocytokines and the Metabolic Complications of ObesityThe Journal of Clinical Endocrinology & Metabolism, 2008
- Stearoyl-Coenzyme A Desaturase 1 Gene Expression Increases after Pioglitazone Treatment and Is Associated with Peroxisomal Proliferator-Activated Receptor-γ ResponsivenessThe Journal of Clinical Endocrinology & Metabolism, 2008
- The Adipocyte as an Endocrine CellEndocrinology and Metabolism Clinics of North America, 2008
- Obesity and Free Fatty AcidsEndocrinology and Metabolism Clinics of North America, 2008
- Translational regulation of lipoprotein lipase in adipocytes: depletion of cellular protein kinase Cα activates binding of the C subunit of protein kinase A to the 3′-untranslated region of the lipoprotein lipase mRNABiochemical Journal, 2008
- Rosiglitazone inhibits metastasis development of a murine mammary tumor cell line LMM3BMC Cancer, 2008
- Thrombospondin-1 Is an Adipokine Associated With Obesity, Adipose Inflammation, and Insulin ResistanceDiabetes, 2008
- Inflammation and insulin resistanceFEBS Letters, 2007
- Increased expression of inflammation-related genes in cultured preadipocytes/stromal vascular cells from obese compared with non-obese Pima IndiansDiabetologia, 2005